The Side Effects of Different Orthopedic Medications

The Side Effects of Different Orthopedic Medications: A High-Yield Review for Surgical Learners

High-Yield Executive Summary

• NSAIDs: Effective for pain and inflammation but impair bone healing and increase risk of gastrointestinal bleeding; avoid in fracture patients requiring rapid union.
• Opioids: Provide potent analgesia but carry risks of respiratory depression, constipation, dependence, and immunosuppression; use the lowest effective dose and duration.
• Bisphosphonates: Reduce osteoclastic activity and fracture risk but may cause osteonecrosis of the jaw and atypical femoral fractures with long-term use.
• Corticosteroids: Potent anti-inflammatory agents but increase infection risk, impair wound healing, and cause osteoporosis; minimize systemic exposure perioperatively.
• Anticoagulants: Essential for VTE prophylaxis but increase bleeding risk; balance thrombosis prevention with surgical hemostasis, especially in joint arthroplasty.

Clinical Fundamentals

Anatomy & Biomechanics:
Orthopedic medications interact with bone remodeling units (osteoblasts, osteoclasts), soft tissues, and systemic physiology. Bone healing depends on a tightly regulated inflammatory phase, cellular proliferation, and remodeling. Medications that alter inflammation or cellular activity can profoundly affect these processes.

Epidemiology:
Orthopedic patients frequently require multimodal pharmacologic management for pain, inflammation, infection, and thromboprophylaxis. Understanding medication side effects is critical to optimizing outcomes and minimizing complications such as delayed union, infection, or systemic adverse events.

Classification & Diagnosis

Medication Classes & Side Effect Profiles:

• NSAIDs (e.g., ibuprofen, naproxen, celecoxib):
• Side effects: GI ulceration, renal impairment, platelet dysfunction, delayed fracture healing.
• Diagnostic pearls: Monitor for signs of GI bleeding and renal insufficiency; avoid in high-risk fracture patients.

• Opioids (e.g., morphine, oxycodone):
• Side effects: Respiratory depression, sedation, constipation, opioid-induced hyperalgesia, dependence.
• Diagnostic pearls: Assess pain control vs. side effects; use validated pain scales and monitor for signs of misuse.

• Bisphosphonates (e.g., alendronate, zoledronic acid):
• Side effects: Osteonecrosis of the jaw (ONJ), atypical femoral fractures, esophagitis.
• Diagnostic pearls: Screen for dental issues pre-treatment; monitor for thigh pain indicative of atypical fractures.

• Corticosteroids (e.g., prednisone, dexamethasone):
• Side effects: Immunosuppression, hyperglycemia, osteoporosis, impaired wound healing.
• Diagnostic pearls: Monitor blood glucose, signs of infection, and wound integrity.

• Anticoagulants (e.g., low molecular weight heparin, warfarin, DOACs):
• Side effects: Bleeding, hematoma formation, thrombocytopenia.
• Diagnostic pearls: Regular INR/PTT monitoring (warfarin), renal function for DOACs, watch for signs of bleeding.

The Decision-Making Algorithm

Non-Operative vs. Operative Medication Management:

• NSAIDs:
• Avoid in acute fracture healing phases; consider short-term use for soft tissue injuries without fracture.
• Use selective COX-2 inhibitors cautiously to reduce GI risk but still weigh bone healing impact.

• Opioids:
• Reserve for moderate to severe pain unresponsive to non-opioid analgesics; taper early to prevent dependence.
• Combine with multimodal analgesia to minimize dose and side effects.

• Bisphosphonates:
• Indicated for osteoporosis and fracture prevention; delay initiation post-fracture surgery to avoid interference with healing.
• Consider drug holidays after 3-5 years to reduce risk of atypical fractures.

• Corticosteroids:
• Use lowest effective dose for inflammatory conditions; avoid systemic steroids perioperatively if possible.
• Consider local steroid injections for joint inflammation with caution.

• Anticoagulants:
• Initiate based on VTE risk stratification (e.g., Caprini score) and surgical bleeding risk.
• Adjust timing around surgery to balance thrombosis and hemorrhage.

Surgical Mastery & Pearls

Intraoperative Considerations:

• NSAIDs: Avoid perioperative use in fracture fixation cases; if used, monitor for delayed union signs intraoperatively and postoperatively.
• Opioids: Use intraoperative opioid-sparing techniques (regional blocks, ketamine) to reduce postoperative opioid requirements.
• Bisphosphonates: No direct intraoperative impact but anticipate altered bone quality; prepare for potential atypical fracture patterns.
• Corticosteroids: Minimize systemic steroids; if unavoidable, optimize glycemic control and infection prophylaxis.
• Anticoagulants: Coordinate timing of last dose pre-op and first dose post-op; be vigilant for hematoma formation and wound complications.

Technical Tips:

• Preoperative medication review is essential to anticipate altered healing or bleeding risks.
• Employ multimodal analgesia protocols to reduce opioid reliance.
• For patients on bisphosphonates, use careful reaming and implant insertion techniques to avoid stress risers.
• Maintain meticulous hemostasis in anticoagulated patients; consider mechanical prophylaxis adjuncts.

Evidence-Based Synthesis

• NSAIDs and Bone Healing: Multiple RCTs and meta-analyses confirm NSAIDs delay fracture healing, particularly with prolonged use >2 weeks. COX-2 selective inhibitors show similar risks, challenging prior assumptions of safety.
• Opioids: Recent literature highlights the immunosuppressive effects of opioids, potentially increasing postoperative infection rates. Enhanced recovery protocols emphasize opioid minimization.
• Bisphosphonates: Landmark trials (e.g., FIT, HORIZON) demonstrate fracture risk reduction but also identify rare complications like ONJ and atypical femoral fractures, prompting guidelines for drug holidays.
• Corticosteroids: Evidence links perioperative steroids to increased infection and poor wound healing; however, short-term low-dose use may be safe in select cases.
• Anticoagulants: Large trials (e.g., RECORD, EINSTEIN) validate DOACs as effective VTE prophylaxis with comparable bleeding risks to LMWH, influencing current perioperative protocols.

Controversies & Evolving Consensus:

• The exact safe window for NSAID use post-fracture remains debated; some advocate limited short-term use.
• Optimal timing for bisphosphonate initiation after fracture fixation is not standardized.
• Balancing anticoagulation and bleeding risk in complex revision arthroplasty requires individualized protocols.

Pro-Tip: Surgical Excellence in Medication Management

• Preoperative Medication Optimization: Conduct a thorough medication reconciliation focusing on orthopedic-impacting drugs; collaborate with pharmacy and medicine colleagues to adjust regimens pre-surgery.
• Multimodal Analgesia Mastery: Integrate regional anesthesia, acetaminophen, NSAIDs (when safe), and adjuvants to minimize opioid exposure and side effects.
• Bone Healing Vigilance: Recognize that even short courses of NSAIDs or corticosteroids can impair healing; educate patients and monitor radiographically for delayed union.
• Anticoagulation Timing Precision: Develop institution-specific protocols for perioperative anticoagulant management, emphasizing timing to reduce hematoma and thrombotic events.
• Patient-Specific Risk Stratification: Tailor medication plans based on comorbidities (renal, hepatic, GI), fracture type, and surgical complexity to optimize outcomes and minimize adverse effects.

This synthesis equips orthopedic surgical learners with a focused, evidence-driven framework to navigate the complex side effect profiles of medications integral to perioperative care, enhancing both patient safety and surgical success.

Last Updated on January 26, 2026 by OrthoNet AI